Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A recurrent pleuropneumonia revealing Erdheim-Chester Disease.
Kherabi Y, Chazal T, Emile JF, Allaham W, Mallart E, de Lastours V, Haroche J, Nguyen Y. Kherabi Y, et al. Respir Med Case Rep. 2023 Apr 7;43:101843. doi: 10.1016/j.rmcr.2023.101843. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37091897 Free PMC article.
Outcomes of Enterococcus faecalis infective endocarditis according to MIC of amoxicillin: a multicentric study.
Do Rego H, Kherabi Y, Corvec S, Plouzeau-Jayle C, Bouchiat C, Macheda G, Meyer S, Cattoir V, Piau C, Guillard T, Zahar JR, Farfour E, Lecomte R, Amara M, Isnard C, Le Monnier A, Pilmis B. Do Rego H, et al. Among authors: kherabi y. JAC Antimicrob Resist. 2024 Nov 1;6(6):dlae167. doi: 10.1093/jacamr/dlae167. eCollection 2024 Dec. JAC Antimicrob Resist. 2024. PMID: 39493937 Free PMC article.
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response.
Lange C, Kherabi Y, Guglielmetti L, Duarte R, Günther G; Tuberculosis Network European Trials group. Lange C, et al. Among authors: kherabi y. Clin Microbiol Infect. 2024 Sep;30(9):1207-1208. doi: 10.1016/j.cmi.2024.06.009. Epub 2024 Jun 18. Clin Microbiol Infect. 2024. PMID: 38901496 No abstract available.
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.
Durier C, Ninove L, van der Werf S, Lefebvre M, Desaint C, Bauer R, Attia M, Lecompte AS, Lachatre M, Maakaroun-Vermesse Z, Nicolas JF, Verdon R, Kiladjian JJ, Loubet P, Schmidt-Mutter C, Corbin V, Ansart S, Melica G, Resch M, Netzer E, Kherabi Y, Tardieu R, Lelièvre JD, Tartour E, Meyer L, de Lamballerie X, Launay O; ANRS002S CoviCompareP group. Durier C, et al. Among authors: kherabi y. Infect Dis Now. 2024 Aug;54(5):104886. doi: 10.1016/j.idnow.2024.104886. Epub 2024 Mar 16. Infect Dis Now. 2024. PMID: 38494117 Free article.
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe.
Günther G, Guglielmetti L, Kherabi Y, Duarte R, Lange C; Tuberculosis Network European Trials group. Günther G, et al. Among authors: kherabi y. Clin Microbiol Infect. 2024 Sep;30(9):1197.e1-1197.e4. doi: 10.1016/j.cmi.2024.03.009. Epub 2024 Mar 13. Clin Microbiol Infect. 2024. PMID: 38490355
30 results